11 min listen
NEJM Interview: Dr. Ameet Sarpatwari on a legal case that could affect market entry of generic and biosimilar drugs.
FromNEJM Interviews
NEJM Interview: Dr. Ameet Sarpatwari on a legal case that could affect market entry of generic and biosimilar drugs.
FromNEJM Interviews
ratings:
Length:
12 minutes
Released:
Feb 8, 2023
Format:
Podcast episode
Description
Dr. Ameet Sarpatwari is an assistant professor of medicine at Harvard Medical School and the assistant director of the Program on Regulation, Therapeutics, and Law at Brigham and Women’s Hospital and Harvard Medical School. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. S.S. Tu and A. Sarpatwari. A “Method of Use” to Prevent Generic and Biosimilar Market Entry. N Engl J Med 2023;388:483-485.
Released:
Feb 8, 2023
Format:
Podcast episode
Titles in the series (100)
NEJM Interview: Cynthia Jackevicius on generic drugs and health care costs. by NEJM Interviews